Literature DB >> 29028946

Mouse Cntnap2 and Human CNTNAP2 ASD Alleles Cell Autonomously Regulate PV+ Cortical Interneurons.

Daniel Vogt1, Kathleen K A Cho1, Samantha M Shelton1, Anirban Paul2, Z Josh Huang2, Vikaas S Sohal1, John L R Rubenstein1.   

Abstract

Human mutations in CNTNAP2 are associated with an array of neuropsychiatric and neurological syndromes, including speech and language disorders, epilepsy, and autism spectrum disorder (ASD). We examined Cntnap2's expression and function in GABAergic cortical interneurons (CINs), where its RNA is present at highest levels in chandelier neurons, PV+ neurons and VIP+ neurons. In vivo functions were studied using both constitutive Cntnap2 null mice and a transplantation assay, the latter to assess cell autonomous phenotypes of medial ganglionic eminence (MGE)-derived CINs. We found that Cntnap2 constitutive null mutants had normal numbers of MGE-derived CINs, but had reduced PV+ CINs. Transplantation assays showed that Cntnap2 cell autonomously regulated the physiology of parvalbumin (PV)+, fast-spiking CINs; no phenotypes were observed in somatostatin+, regular spiking, CINs. We also tested the effects of 4 human CNTNAP2 ASD missense mutations in vivo, and found that they impaired PV+ CIN development. Together, these data reveal that reduced CNTNAP2 function impairs PV+ CINs, a cell type with important roles in regulating cortical circuits.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29028946      PMCID: PMC6455910          DOI: 10.1093/cercor/bhx248

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  63 in total

1.  CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder.

Authors:  Annemieke J M H Verkerk; Carol A Mathews; Marijke Joosse; Bert H J Eussen; Peter Heutink; Ben A Oostra
Journal:  Genomics       Date:  2003-07       Impact factor: 5.736

2.  The parvalbumin/somatostatin ratio is increased in Pten mutant mice and by human PTEN ASD alleles.

Authors:  Daniel Vogt; Kathleen K A Cho; Anthony T Lee; Vikaas S Sohal; John L R Rubenstein
Journal:  Cell Rep       Date:  2015-04-30       Impact factor: 9.423

3.  ERK/MAPK regulates the Kv4.2 potassium channel by direct phosphorylation of the pore-forming subunit.

Authors:  Laura A Schrader; Shari G Birnbaum; Brian M Nadin; Yajun Ren; Duy Bui; Anne E Anderson; J David Sweatt
Journal:  Am J Physiol Cell Physiol       Date:  2005-10-26       Impact factor: 4.249

Review 4.  Shining a light on CNTNAP2: complex functions to complex disorders.

Authors:  Pedro Rodenas-Cuadrado; Joses Ho; Sonja C Vernes
Journal:  Eur J Hum Genet       Date:  2013-05-29       Impact factor: 4.246

5.  Candidate autism gene screen identifies critical role for cell-adhesion molecule CASPR2 in dendritic arborization and spine development.

Authors:  Garret R Anderson; Timothy Galfin; Wei Xu; Jason Aoto; Robert C Malenka; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-16       Impact factor: 11.205

6.  Strategies and Tools for Combinatorial Targeting of GABAergic Neurons in Mouse Cerebral Cortex.

Authors:  Miao He; Jason Tucciarone; SooHyun Lee; Maximiliano José Nigro; Yongsoo Kim; Jesse Maurica Levine; Sean Michael Kelly; Illya Krugikov; Priscilla Wu; Yang Chen; Ling Gong; Yongjie Hou; Pavel Osten; Bernardo Rudy; Z Josh Huang
Journal:  Neuron       Date:  2016-09-08       Impact factor: 17.173

7.  Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene.

Authors:  Maricela Alarcón; Brett S Abrahams; Jennifer L Stone; Jacqueline A Duvall; Julia V Perederiy; Jamee M Bomar; Jonathan Sebat; Michael Wigler; Christa L Martin; David H Ledbetter; Stanley F Nelson; Rita M Cantor; Daniel H Geschwind
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

8.  Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders.

Authors:  Betul Bakkaloglu; Brian J O'Roak; Angeliki Louvi; Abha R Gupta; Jesse F Abelson; Thomas M Morgan; Katarzyna Chawarska; Ami Klin; A Gulhan Ercan-Sencicek; Althea A Stillman; Gamze Tanriover; Brett S Abrahams; Jackie A Duvall; Elissa M Robbins; Daniel H Geschwind; Thomas Biederer; Murat Gunel; Richard P Lifton; Matthew W State
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

9.  Diagnostic whole genome sequencing and split-read mapping for nucleotide resolution breakpoint identification in CNTNAP2 deficiency syndrome.

Authors:  Christopher M Watson; Laura A Crinnion; Antigoni Tzika; Alison Mills; Andrea Coates; Maria Pendlebury; Sarah Hewitt; Sally M Harrison; Catherine Daly; Paul Roberts; Ian M Carr; Eamonn G Sheridan; David T Bonthron
Journal:  Am J Med Genet A       Date:  2014-07-16       Impact factor: 2.802

10.  Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission.

Authors:  T Karayannis; E Au; J C Patel; I Kruglikov; S Markx; R Delorme; D Héron; D Salomon; J Glessner; S Restituito; A Gordon; L Rodriguez-Murillo; N C Roy; J A Gogos; B Rudy; M E Rice; M Karayiorgou; H Hakonarson; B Keren; G Huguet; T Bourgeron; C Hoeffer; R W Tsien; E Peles; G Fishell
Journal:  Nature       Date:  2014-07-10       Impact factor: 69.504

View more
  21 in total

1.  CNTNAP2 is targeted to endosomes by the polarity protein PAR3.

Authors:  Ruoqi Gao; Christopher P Pratt; Sehyoun Yoon; Maria Dolores Martin-de-Saavedra; Marc P Forrest; Peter Penzes
Journal:  Eur J Neurosci       Date:  2019-12-02       Impact factor: 3.386

Review 2.  Application of Medial Ganglionic Eminence Cell Transplantation in Diseases Associated With Interneuron Disorders.

Authors:  Danping Li; Qiongfang Wu; Xiaohua Han
Journal:  Front Cell Neurosci       Date:  2022-07-05       Impact factor: 6.147

3.  Dysfunction of Trio GEF1 involves in excitatory/inhibitory imbalance and autism-like behaviors through regulation of interneuron migration.

Authors:  Xiaoxuan Sun; Lifang Wang; Chengwen Wei; Mengwen Sun; Qiongwei Li; Hu Meng; Weihua Yue; Dai Zhang; Jun Li
Journal:  Mol Psychiatry       Date:  2021-05-07       Impact factor: 15.992

4.  Cortical Excitation:Inhibition Imbalance Causes Abnormal Brain Network Dynamics as Observed in Neurodevelopmental Disorders.

Authors:  Marija Markicevic; Ben D Fulcher; Christopher Lewis; Fritjof Helmchen; Markus Rudin; Valerio Zerbi; Nicole Wenderoth
Journal:  Cereb Cortex       Date:  2020-07-30       Impact factor: 5.357

5.  A Composite Sketch of Fast-Spiking Parvalbumin-Positive Neurons.

Authors:  Odile Bartholome; Orianne de la Brassinne Bonardeaux; Virginie Neirinckx; Bernard Rogister
Journal:  Cereb Cortex Commun       Date:  2020-06-19

6.  Sensitive period for rescuing parvalbumin interneurons connectivity and social behavior deficits caused by TSC1 loss.

Authors:  Clara A Amegandjin; Mayukh Choudhury; Vidya Jadhav; Josianne Nunes Carriço; Ariane Quintal; Martin Berryer; Marina Snapyan; Bidisha Chattopadhyaya; Armen Saghatelyan; Graziella Di Cristo
Journal:  Nat Commun       Date:  2021-06-16       Impact factor: 14.919

Review 7.  Dendritic Integration Dysfunction in Neurodevelopmental Disorders.

Authors:  Andrew D Nelson; Kevin J Bender
Journal:  Dev Neurosci       Date:  2021-06-17       Impact factor: 3.421

8.  Lateralized Decrease of Parvalbumin+ Cells in the Somatosensory Cortex of ASD Models Is Correlated with Unilateral Tactile Hypersensitivity.

Authors:  Tara Deemyad; Stephanie Puig; Andrew E Papale; Hang Qi; Gregory M LaRocca; Deepthi Aravind; Emma LaNoce; Nathaniel N Urban
Journal:  Cereb Cortex       Date:  2022-01-22       Impact factor: 4.861

Review 9.  Common Ribs of Inhibitory Synaptic Dysfunction in the Umbrella of Neurodevelopmental Disorders.

Authors:  Rachel Ali Rodriguez; Christina Joya; Rochelle M Hines
Journal:  Front Mol Neurosci       Date:  2018-04-24       Impact factor: 5.639

10.  CNTNAP2 Heterozygous Missense Variants: Risk Factors for Autism Spectrum Disorder and/or Other Pathologies?

Authors:  Giorgia Canali; Laurence Goutebroze
Journal:  J Exp Neurosci       Date:  2018-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.